Effect of Self-regulated Learning on Academic Performance Among Physical Education Students
Launched by XIE HUIJUAN · Sep 19, 2024
Trial Information
Current as of August 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
In this study, the experimental group received a 12-week (John, 2017) self-regulated learning strategy based on a learning model teaching intervention designed for this study. In contrast, the control group discussed and studied traditional learning content for 12 weeks with the teacher, and the students in the experimental group learned the self-regulated learning strategy. A cluster-randomised controlled trial (CRCT) design was used, and the experimental and control groups were randomly assigned to two schools. After 12 weeks of learning, both groups were required to conduct a learning pe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. University students;
- • 2. Major in Physical Education;
- • 3. Health;
- • 4. Able to attend all evaluation;
- • 5. Understand the study purposes and procedures;
- • 6. No previous experience performing self-regulated learning strategy.
- Exclusion Criteria:
- • 1. University students not majoring in Physical Education;
- • 2. Exclude participants who have not finished all evaluation;
- • 3. Not understanding the study purposes and procedures;
- • 4. Participants with an experience in self-regulated learning strategy.
About Xie Huijuan
Xie Huijuan is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the design and execution of clinical studies, the organization focuses on innovative therapies and cutting-edge technologies across various therapeutic areas. Xie Huijuan prioritizes collaboration with healthcare professionals and regulatory bodies to ensure the highest standards of ethical compliance and scientific rigor. By fostering a patient-centered approach, the sponsor aims to contribute meaningful data that enhances the understanding of treatment efficacy and safety, ultimately driving the development of new healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yuncheng, Shanxi, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported